Rapid Bacterial Testing for Spacecraft Water by Pyle, Barry H. et al.
-/'_/_'_///_ "/' W ,2--t 206364
RAPID BACTERIAL TESTING FOR SPACECRAFT WATER
NASA Research Grant NAGW-5001
Report to NASA Headquarters, Washington D.C.
OCTOBER 1996
by
John T. Lisle, Barry H. Pyle and Gordon A. McFeters
Department of Microbiology, Montana State University
Bozeman, Montana 59717
.L
PERSONNEL:
Activity on this project commenced in the spring of 1996 with Dr. McFeters as principal
investigator. Dr. Pyle has acted in the role of co-principal investigator, although he will be taking
a less active role than anticipated because of other research commitments in the laboratory,
although he is available on a day-to-day basis. As a result, it was decided to appoint a post-
doctoral research assistant. Advertisements were placed nationally and locally, and John Lisle,
who was completing his doctorate in the Public Health program at the University of South
Florida, Tampa. Dr. Lisle joined us in June, 1996. Susan Broadaway, Research Associate,
undergraduate student assistants Ryan Storfa, Carla Johnsrud, and Scott Burnett, along with
undergraduate lab aids (College Work Study) Jennifer Canwright and Kari Farrell (Summer 1996)
and Nicole Pilakowsky and Brian VanderVen (Fall 1996 through Spring 1997). Undergraduate
student assistants are enrolled for independent study research credits, and are not paid for this
work, and the cost of CWS is shared over several projects.
PROGRESS:
Progress will be addressed by Task (Research Tasks, pages 7-10 of the original proposal).
The majority of time spent on the project to date has been focused on familiarizing the post-
doctoral research assistant (Dr. John Lisle) with the techniques developed in this laboratory and
modification of those techniques to meet the objectives of the project.
Task 1. Organism Selection. Escherichia coli O157:H7 is currently being evaluated as the
reference strain for the development of Tasks 2-6. This bacterium is routinely used in this
laboratory and is well characterized in regard to its growth requirements and characteristics. The
other species listed in the proposal are on site and will be evaluated using the protocols developed
with E. coli O157:H7.
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Task 2. Antibody and Probe Acquisition or Production. To date the following labeled and
unlabeled antibodies havebeen purchased for use in direct and indirect antibody staining assays,
respectively: (direct) anti-E, coli O157:H7/FITC labeled, (indirect) anti-E, coli O157:H7, anti-
KlebsieUa, anti-SalmoneUa and anti-Pseudomonas aeruginosa. The secondary, labeled antibodies
used in the indirect assays include the FITC and TRITC fluorochromes. Currently, E. coli
O 157 :H7 is being used to optimize antibody staining assays in conjunction with fluorescent probes
used to assess physiological status (see Task 6).
Oligonucleotide probes complimentary to 16s rRNA sequences within Ps. aeruginosa are
available in this laboratory from previous studies. We are currently performing preliminary
experiments using these probes to optimize a fluorescent in situ hybridization (FISH) protocol.
Upon the development of a optimized, but general, protocol for this technique we will purchase
the 16s rRNA probes for other bacteria listed in the proposal.
Task 3. Antibody and Probe Specificity. Due to working with pure E. coli O157:H7 cultures,
to date we have not evaluated the specificity of two or more fluorescently labeled antibody in a
consortia of bacteria. However, if we continue to use our current suppliers, we anticipate minimal
problems with specificity since determining the degree of cross-reactivity of an antibody with
bacteria which may be commonly found associated with the target bacterium is a standard quality
assurance assay. If we decide to develop a specific antibody, Montana ImmunoTech, Inc. will be
employed to produce the antibodies and we will be responsible for determination of its specificity.
As stated in Task 2, the FISH protocol has not yet been developed. Oligonucleotide probe
specificity is central to a reliable FISH assay. The FISH assays we are currently using as general
protocols, outline specific factors that must be addressed and optimized to achieve specificity and
reproducibility.
Task 4. Membrane Filtration Optimization. See Task 6.
Task 5. Physiological Assessment Methods. See Task 6.
Task 6. Combination of Techniques. Most of the efforts to date have been directed towards the
development of a technique that allows the staining of bacteria retained on black polycarbonate
filters with two or more fluorochrotnes. E. coli O157:H7 has been selected as a reference strain
for development of a general protocol that will be applied and modified if necessary for the other
bacterial species listed in the proposal. The objectives of this approach are to determine from a
single filter the total number of bacteria present in a water sample, if a specific strain of bacteria
is present within the total population and if these bacteria are viable or dead. The different
categories and the stains or probes used to determine these criteria include: (1) total cell counts
using DAPI and acridine orange, (2) identification of specific strains of bacteria using TRITC and
FITC labeled secondary antibodies raised against anti-E, coli O157:H7 primary antibodies, (3)
detection of respiratory activity using CTC, (4) detection of nutrient responsiveness using the
direct viable count (DVC) technique, (5) detection of membrane potential using calcofluor white,
DiOC6(3) and Rh123, (6) detection of loss of membrane potential using DiB2kC (3) and (7)
determination of viability using the commercially available Live/Dead BacLight kit (Molecular
Probes,Inc., Eugene,OR). Preliminarystudieshavebeenconductedto optimizeconditionsfor
eachstainor substratealoneandin variouscombinations.In additionto theseassays,agarplate
assaysfor determinationof total viable counts (R2A agar) and lethality and injury within
populationsof bacteria after exposure to disinfection (TLY and TLYD agar) have been
incorporated.Calcofluor white andDiOC6(3)havedemonstratedunpredictableresultsandwill
not beevaluatedfurther.
A modified versionof theCTC/fluorescentantibody filter assayoutlinedin Figure 2 of
the original proposalhasbeenused with E. coli O157:H7 cells. Bacteriaretainedon black
polycarbonatefilters were incubatedwith CTC, stained with TRITC labeled fluorescent
antibodies,followed by stainingwith DiBAC4(3).The modified protocol producedpromising
results.This is encouragingsincetheability to evaluatea samplewith morethanonefluorogenic
stainor probeshouldfacilitatetheuseof laserscanningtechnologiescoupledwith imageanalysis
for rapid detectionof targetbacterialspecies.Othercombinationsof staresandsubstratesfrom
the list previously mentionedare being evaluatedin regard to their applicability using this
protocol.
We arealsocontinuingresearchon theuseof immunomagneticseparationasa meansof
concentratingspecificbacteriafrom waterandfoods. To determinethe efficiency of bacterial
detectionby immunomagneticseparation(IMS) andthecompatibility of IMS with cyanoditolyl
tetrazoliumchloride (CTC) incubationto determinerespiratory activity, using the pathogen
Escherichiacoli O157:H7. Staining with DAPI or a specific fluorescein-conjugated anti-O157
antibody was used to allow visualization of bacteria by epifluorescence microscopy. Suspensions
were also plated on tryptone lactose yeast extract (TLY) agar. E. coli O157:H7 grown in broth
were diluted in phosphate buffered saline (PBS) or sterile water and reacted with immunomagnetic
beads coated with anti-O157 specific antiserum. Beads were obtained Dynal (Dynabeads), Bangs
Laboratories (Bangs), or Milltenyi Biotec (Mini Macs). The largest of these, Dynabeads (2.8_zm),
were obtained pre-coated with anti-O157 antibody. Bangs beads (ca. 0.6/_m) and Mini Macs (ca.
0.05#m) were coated with rabbit anti-O157 serum (Difco).
Initial experiments with Dynal beads achieved recovery rates of ca. 80 %, and the presence
of the beads did not affect the determination of respiratory activity indicated by CTC reduction.
Mini Macs beads recovered more than 94 % of the bacteria in a 50ml suspension containing ca.
10 s CFU/ml of bacteria.
Task 9. Effects of Growth Conditions and Stressors. Even though this task has been scheduled
for the second year, preliminary studies are being conducted to optimize conditions for evaluation
of fluorogenic stains and probes after disinfection or starvation. E. coli O157:H7 is being used
as the reference strain. Preliminary studies have been completed that evaluated the specificity and
reliability of TRITC labeled fluorescent antibodies, CTC, DiBAC4(3) and the Live/Dead BacLight
kit after E. coli O157:H7 cultures were exposed to lethal temperatures and concentrations of
formalin, ethanol and chlorine. Equal volumes of the inactivated culture and a viable culture of
the same strain were mixed and stained or probed. Cell counts using the listed stains and probes
were compared to total cell counts using DAPI and total viable counts using R2A agar. All stains
and probes evaluated demonstrated consistent and predictable results under these experimental
conditions.
Currently,protocolsfor theevaluationof sub-lethalconcentrationsof chlorine arebeing
developed.Sub-lethalinjury isbeingevaluatedusingthe same stains and probes listed above, with
the addition of Rh123. Injury is also being determined by use of TLY and TLYD plate agars,
where TLYD plates contain deoxycholate which inhibits the growth of injured bacteria. The ratio
of (TLY-TLYD)/TLY plate counts gives an estimate of injury in the exposed population.
Comparisons of the stain/probe cell counts to the plate counts will provide an indication of the
applicability of the listed stains and probes for evaluation of sub-lethal injury. The protocol
developed for these types of assays will be used and modified if necessary for the starvation
experiments.
Task 11. Preliminary Automation Assessment. We have recently upgraded our computer
system to make the image analysis software system, Optimas, run more efficiently. Also, we have
ordered a ChemScan analysis system using Department of Defence (Army) funding. This system
includes a dual channel laser that can excite two different fluorochromes or probes simultaneously.
It can scan an entire filter in less than three minutes, locating and counting cells of specific size
and fuorescence (i.e., color). We will be incorporating a computerized mechanical microscope
stage to confirm all positive cell locations by direct microscopic examination. The ChemScan
compliments our primary objective of rapid identification of specific bacteria on a filter.
RESEARCH PLANS:
1. Evaluations of the fluorogenic stains and probes will continue. E. coli O157:H7 will be used
as the reference strain for optimizing protocols. We anticipate the continued use of the fluorescent
antibodies (TRITC and FITC labeled) in conjunction with CTC, Rh123, DiBAC4(3), DAPI and
acridine orange. Chemunex, the manufacturer of the ChemScan analyzer system, also makes a
fluorogenic probe, Chemchrome B, which will be incorporated into the suite of probes to evaluate
once their system is on site. Regardless of the combination of stains and probes all will be
evaluated on membrane filters.
2. Development of a FISH protocol that will be applicable to our conditions will be continued.
Complimentary 16s rRNA probes to Ps. aeruginosa and currently in our laboratory will be
evaluated first. Once this protocol has been adequately optimized other probes will be ordered for
a select number of other species.
3. Currently, protocols to evaluate the effects of disinfection and the resulting lethality, injury
on stain and/or probe specificity and reliability are being developed. E. coli O157:H7 is the
reference strain and chlorine the disinfectant the reference protocol is being developed around.
Upon completion of this work, the resulting protocol will be extended to other species and
disinfectants (e.g., iodine). Similar disinfectant experiments will then be conducted on the same
species after starvation to evaluate the effects of starvation on disinfection resistance and the
applicability of the stains and probes.
4. Development of the immunomagnetic separation system will continue. Combined with the
4
rapid methods described above, with enumeration by the ChemScan, we anticipate that this will
provide a highly sensitive technique for the detection of specific, active bacteria.
PRESENTATIONS AND PUBLICATIONS:
Dr. McFeters was invited to attend the NASA Advanced Technologies Workshop,
Enhancement of Human Health and Performance in Space, held at the Center for Advanced Space
Studies, Houston, Texas, in September, 1996. He also visited with colleagues at Johnson Space
Center.
In November, 1996, Dr. McFeters will present a paper at the American Water Works
Association Water Quality Technology meeting in Boston. This paper, entitled "Detection of
Specific Respiring Bacteria in Water Using Immunomagnetic Separation Combined with
Cyanoditolyl Tetrazolium Chloride", includes data which shows that immunomagnetic separation
can be an effective way of concentrating bacteria such as E. coli O157:H7 from water and other
fluids including food suspensions. Another presentation, "Effect of Chlorine-Induced Injury on
Reaction Kinetics of Coliforms and E. coli in Colisure and LTB" will be given by Dr. McFeters.
An abstract has been submitted for the 27th International Conference on Environmental
Systems, to be held at Lake Tahoe in July 1997 (copy attached). Entitled "Rapid Detection of
Bacteria in Spacecraft Water Systems", this presentation will describe and discuss our research
in this area.
We are preparing an abstract to be submitted for the American Society for Microbiology
Annual Meeting to be held in Miami Beach next May, on rapid, direct microscopic methods for
enumeration of specific, active bacteria.
TRAVEL PLANS:
During his visit to Boston for the AWWA WQTC meeting in November, Dr. McFeters
will also meet with Millipore Corporation to discuss research utilizing their new Rapid Micro
Detection System. That company is providing us with an instrument to include in our methods
development program.
Dr. Pyle and Dr. Lisle will travel to Paris, France, in December for training in the
installation and use of the ChemSc_n instrument by Chemunex.
• Dr. McFeters and at least one other team member will attend the American Society for
Microbiology Annual Meeting at Miami Beach next May to present research results and confer
with colleagues who attend that meeting.
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Directions: Update to reflect any changes in the direct_bn of the task. However, please limit the length of the text. Significant alterations,
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In water microbiology, there is a need for rapid methods to enumerate specific viable bacteria.
This is a particular concern in relation to water which will be reclaimed for potable use on Space
Station Alpha. Our principal objective is to develop procedures which will permit the detection of
specific marker bacteria which would be used to monitor the performance of the water reclamation
and storage systems. In addition, the techniques will be applicable to the detection of particular
pathogenic bacteria. Our novel approach (Pat. Pending), which utilizes membrane filtration and
combines a fiuorochrome for assessment of respiratory activity with specific fluorescent antibody
detection of waterborne bacteria, will be evaluated in comparison with molecular methods which
will be developed in this project. These include fluorescent in situ hybridization following
membrane filtration and microcolony formation, to permit rapid quantitation of specific, viable
bacteria. Fluorescent in situ PCR will also be investigated for sensitive detection of specific
bacteria. Results will be applicable not only to Spacecraft systems but will also have applications
for earth-based situations. Similar methodologies would be of great value for the examination of
clinical and fecal specimens, potable waters, natural waters, foods, and soils, for more timely and
reliable detection of specific microbial contamination. Other applications include the examination
of purified waters used in the pharmaceutical industry, laboratories and the electronic industry.
I"lWe will develop analytical procedures to identify and quantify bacteria in waste water and product
water on spacecraft, permitting more timely measurement and control of bacterial contaminants,
and facilitating development of standards and countermeasures to optimize crew health, safety and
productivity.
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Efforts have been directed towards the development of a technique that allows the
staining of bacteria retained on black polycarbonate filters with two or more fluorochromes to
determine, from a single filter: (a) the total number of bacteria present in a water sample; Co)
if a specific strain of bacteria is present within the total population; and, (c) if these bacteria
are viable. The different stains or probes used include: (1) total cell counts using DAPI and
acridine orange, (2) identification of specific strains of bacteria using TRITC and FITC labeled
secondary antibodies raised against anti-E, coli O157:H7 primary antibodies, (3) detection of
respiratory activity using CTC, (4) detection of nutrient responsiveness using the direct viable
count (DVC) technique, (5) detection of membrane potential using calcofluor white, DiOC6(3)
and Rh123, (6) detection of loss of membrane potential using DiBACa(3) and (7) determination
of viability using the commercially available Live/Dead BacLight kit (Molecular Probes, Inc.,
Eugene, OR). In addition to these assays, agar plate assays for determination of total viable
counts (R2A agar) and lethality and injury within populations of bacteria after exposure to
disinfection (TLY and TLYD agar) have been incorporated.
A modified version of the CTC/fluorescent antibody filter assay has been used with E.
coli O157:H7 cells. Bacteria retained on black polycarbonate filters were incubated with CTC,
stained with TRITC labeled fluorescent antibodies, followed by staining with DiBAC4(3). The
modified protocol produced promising results. In additon, highly efficient (> 90%) bacterial
detection by immunomagnetic separation (IMS) and the compatibility of IMS with cyanoditolyl
tetrazolium chloride (CTC) incubation to determine respiratory activity, using E. coli
O157:H7 has been achieved. Staining with DAPI or a specific fluorescein-conjugated anti-
O157 antibody was used to allow visualization of bacteria by epifluorescence microscopy.
TRITC labeled fluorescent antibodies, CTC, DiBAC4(3) and the Live/Dead BacLight kit were
tested using E. coli O157:H7 cultures after exposure to lethal temperatures and concentrations
of formalin, ethanol and chlorine. All stains and probes evaluated demonstrated consistent and
predictable results with disinfected and starved bacteria. Sub-lethal chlorine injury is being
evaluated using the same stains and probes listed above, with the addition of Rh123. Injury is
also being determined by use of TLY and TLYD plate agars, where TLYD plates contain
deoxycholate which inhibits the growth of injured bacteria.
A ChemScan analysis system (Chemunex, France) has been acquired using Department
of Defence (Army) funding. This system includes a dual channel laser that can excite two
different fluorochromes or probes simultaneously. It can scan an entire filter (25mm diam.) in
less than three minutes, locating and counting cells of specific size and fluorescence (i.e.,
color). A computerized mechanical microscope stage is used to confirm positive cells.
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The techniques we are developing for rapid detection of specific bacteria in conjunction with
viability assessment have attracted significant attention among environmental microbiologists.
The combination of immunomagnetic separation with the CTC respiration assay and
fluorescent antibody staining permits direct detection of bacterial contaminants within 6-7
hours. Most other methods employ a 12-24 hour enrichment prior to identification. A patent
application on this technology is currently being evaluated. One of the impediments to timely
assessment of water and food quality has been the time required to obtain results using
traditional or even novel techniques. These procedures will be used for monitoring potable
water, foods, and parenteral (injectible) liquids.
Our experiments with disinfection and starvation, using these new methods to detect
bacteria, will generate more reliable data On bacterial injury, lethality, and survival.
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In water microbiology, there is a need for rapid methods to enumerate specific viable bacteria.
This is a particular concern in relation to water which will be reclaimed for potable use on
Space Station Alpha. Our principal objective is to develop procedures which will permit the
detection of specific marker bacteria which would be used to monitor the performance of the
water reclamation and storage systems. In addition, the techniques will be applicable to the
detection of particular pathogenic bacteria. Our novel approach (patent pending), which
utilizes membrane filtration and combines a fluorochrome for assessment of respiratory
activity with specific fluorescent antibody detection of waterborne bacteria, will be evaluated
in comparison with molecular methods which will be developed in this project. These include
fluorescent in situ hybridization following membrane filtration and microcolony formation, to
permit rapid quantitation of specific, viable bacteria. Fluorescent in situ PCR will also be
investigated for sensitive detection of specific bacteria. Results will be applicable not only to
spacecraft systems but will also have applications for Earth-based situations. Similar
methodologies would be of great value for the examination of clinical and fecal specimens,
potable waters, natural waters, foods, and soils, for more timely and reliable detection of
specific microbial contamination. Other applications include the examination of purified
waters used in the pharmaceutical industry, laboratories, and the electronics industry.
Experiments were performed using a suite of fluorescent stains that demonstrate a range of
cellular physiological activities and properties that are related to viability, These stains were
applied to the pathogen Escherichia coli O157:H7 exposed to low levels of disinfection with
chlorine. Freshly prepared suspensions and starved cultures were examined. With earlier
funding, we developed a rapid method for detecting specific respiring bacteria. A prototype
system has been demonstrated with Escherichia coli O 157:H7 suspensions and inoculated
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gound beef. In FY97, we have continued evaluation of this hybdrid technique, which
includes immunomagnetic separation, and incubation with cyanoditolyl tetrazolium chloride
(CTC) to determine respiratory, activity., followed by fluorescent antibody staining
(IMS/CTC/FAb).
Our objective is to
_develop analytical procedures to identify and quantify bacteria in waste water and
product water on spacecraft, permitting more timely measurement and control of bacterial
contaminants, and facilitating development of standards and countermeasures to optimize crew
health, safety, and productivity.
58-5-2
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B. Task Progress
DIRECTIONS; Task Progress must reflect any progress made during FY97 (Oct. 1, 1996 to Sept.
30, 1997) even if the project was active for only part of this time period. If this task
was included in the FY96 Task Book, PLEASE DO NOT DUPLICATE THE FY96
TASK PROGRESS. If you wish to refer to last year's Task Progress as a guide, you
can access the online Task Book Data Base (via http://peerl.idi.usra.edu) or contact
John Nelson at 202-488-5131 (or john.nelson@hq.nasa.gov)for a copy.
Answers to the following questions should help to formulate an appropriate statement
of progress: What has been accomplished thus far (and particularly during FY97)?
What questions have been answered? What new questions have arisen? How does
this fiscal year's progress affect future work on this task?
We have used a suite of stains and probes, in conjunction with viable plate counts, to assess the
effect of chlorine disinfection on membrane potential (Rhodamine t23 [Rh123] and DiBAC,_,3),
membrane integrity (BacLight give/Dead Kit, Molecular Probes Inc.), respiratory activity
(CTC). and substrate responsiveness (direct viable count [DVC]) in E. ¢oli O157:H7. After a 5
minute exposure to chlorine, physiological indices were affected in the following order: viable
plate count > substrate responsiveness > membrane potential > respiratory_ activity > membrane
integrity. In situ assessment of physiological activity using a multi-phasic approach, as
demonstrated in this study, permits more comprehensive decisions to be made in regard to
determining the site and extent of injury, in bacterial cells.
In related experiments, cultures ofE. coli O157:H7 were starved in M9 minimal medium with
no added carbon source, for 14 days at 21-23°C. In addition to the assays listed above,
intracellular esterase activity was determined using Fluorassure (Chemunex. France) in which
case bacteria on filters were enumerated with a Scan RDI (Chemunex) rapid laser scanner.
Assays were performed to demonstate the influence of starvation on susceptibility to
disinfection with 0.5 ppm chlorine. Results indicated that between inoculation and starvation
through day 5. the assays used demonstrated an increased number of physiologically active
cells, with numbers remaining relatively constant through day 14. However, cells exhibiting
membrane potential and substrate responsiveness declined as starvation progressed, while
resistance to chlorine disinfection increased as indicated by the percentage of injured cells.
Injury. decreased from 92.6% of cells at time 0. to 44.3% by day 5, and remained relatively
constant through day 14 (35.3%). The results show that in the starvation conditions used, this
strain of E. coti maintained physiological activitv while increasing resistance to chlorination.
For the IMS/CTC/FAb evaluation, we have added the more rapid and sensitive Scan RDI
system. Using the IMS/CTC/FAb procedure, we recovered more than 86% of the O157 cells in
(9_g-
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the inoculum, with re m'ession coefficients >0.95 when comparing the CTC/FAb counts with
those obtained by plate count enumeration of cells recovered by immunomagnetic beads.
Epifluorescence microscopy has a lower detection limit of ca. 103 ceils per g or per ml of
sample, while the Scan RDI system permits detection of 1 cell per g or per ml.
The results of experiments conducted in this period demonstrate the utility and versatility of
the novel rapid analytical methodology under investigation. Although only one of the present
suite of physiological fluorochromes as well as the IMS/CTC/FAb were compatible with the
current Scan RDI instrumentation, our results thus far provide justification for optimism
concerning the prospect of applying this powerful new rapid approach to bacterial detection in
a wide range of settings. Discussions w_th the manufacturer of the Scan RDI system continue
to focus on avenues for improving the versatility and cost of this instrument as it is
reconfigured. In addition, we will continue to evaluate and validate additional physiological
fluorochromes for this kind of instrumentation, based on our experience with stains that asse_s
specific physiological targets. Ultimately, this line of investigation will lead to more accurate
methods for bacterial identification and viability_ determination associated with this rapid
detection strategy,
78-5-3.
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C. Earth Benefits
DIRECTIONS: Please update the Earth Benefits for this project as necessary. If this task was not
included in last year's Task Book, please provide a statement of Earth Benefits.
Answers to the following questions should help to formulate an appropriate statement
of Earth Benefits: Does this research seek to understand a disease or malady that
affects humans on Earth and/or in space? Does this research seek to develop new
therapeutics or protocols for alleviating symptoms of a disease or malady on Earth?
Will this research yield a new understanding of basic biological processes? What
relationship does this task-posit between processes on Earth and in space? What
impact could the results of this research have on the human race? What benefits are
foreseen by the development of this new technology? _
The techniques we are developing for rapid detection of specific bacteria in conjunction with
viability assessment have attracted significant attention among environmental microbiologists.
The combination of immunomagnetic separation with the CTC respiration assay and
fluorescent antibody staining permits direct detection of bacterial contaminants within six-
seven hours. Most other methods employ a 12-24 hour enrichment prior to identification. A
patent application on this technology is currently being evaluated. One of the impediments to
timely assessment of water and food quality has been the time required to obtain results using
traditional or even novel techniques. These procedures will be used for monitoring potable
water, foods, and parenteral (injectible) liquids.
Our experiments with disinfection and starvation, using these new methods to detect bacteria,
will generate more reliable data on bacterial injury, lethality, and survival. The combination of
methodological approaches for bacterial concentration, detection and viability assessment
being investifated has significant benefits both immediately and in the long-term. For
example, our present target bacteriurfi (E. coli O 157:H7) is currently a persistent and
significant food borne health threat in the U.S. Other aspects of developing this technology
hay been funded by the U.S. Department of Defense (Army) and the National Institutes of
Health (Environmental Health Institute). A patent is pending, and we have partnered with
Montana ImmunTech. Inc.. a local biotechnology development company to bring this
_¢¢hnique to the U.S. and international market place. Ultimately, the development of novel
antibodies may lead to therapeutics and possibly vaccines for the treatment of a range of
enteric diseases which are caused by bacteria.
[t is anticipated that our new methodological approach will be applied in studies by others to
determine the ecology orE. coli O157 and related bacteria in the food source animal
population and their environment and. as a consequence, assist in its reduction or elimination.
8g-5g
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I1 Some version of this technology might also be amenable to miniaturization and use in
protecting crew health on space vehicles. It is also applicable to the rapid detection of other
target bacteria in a range of contexts including industrial, clinical and environmental settings,
98-5g
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SECTION III. FY97 Bibliography
DJBEC_TJQJ_L_ Please provide complete citation source information for publications, presentations,
and other accomplishments resulting from this task DURING FY97 ONLy (Oct. 1,
1996 to Sept. 30, 1997). In addition, please send a complete reprint or photocopy of
each publication. If there are no FY97 bibliographic entries to be included, please
enter "NONE" into the shaded box below.
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